What Is PO-SCORAD, and Why Does It Matter for Your Child’s Eczema?

If you have spent any time reading about the recent pediatric eczema study published in Frontiers in Allergy, you have run into one unfamiliar acronym over and over: PO-SCORAD. It is the tool researchers used to measure the 52.9% average improvement seen in children enrolled in Dr. Ana-Maria Temple’s Eczema Transformation Program, and understanding it helps you understand exactly what that number means.

PO-SCORAD, Defined

PO-SCORAD stands for Patient-Oriented Scoring of Atopic Dermatitis. It is a validated, self-reported measure of eczema severity, meaning parents and caregivers complete it at home rather than relying solely on a clinician’s brief visual assessment during an office visit.

That distinction matters more than it sounds. A five-minute exam in a bright office does not capture what happens at 2 a.m., when a child is scratching in their sleep, or how much skin was affected on the worst day of the week rather than the calmest. PO-SCORAD is built to capture the fuller picture.

What PO-SCORAD Actually Measures

The tool combines three separate domains into a single total score on a scale of 0 to 103, with lower scores indicating better performance.

  1. Affected surface area. Parents mark which regions of the body show eczema using a body diagram, and each area contributes a percentage toward the total.
  2. Intensity of symptoms. Six specific signs, redness, swelling, oozing or crusting, scratch marks, skin thickening, and dryness, are each rated from 0 (absent) to 3 (severe).
  3. Subjective symptoms. Parents rate their child’s itching and sleep loss over the past 3 days on a scale of 1 to 10. This is the domain that captures what a clinical exam often misses entirely: how much the child is actually suffering day to day.

These three domains are added together to produce the total PO-SCORAD score.

Join the Live Eczema Masterclass

Reading the Scale

Clear 0–2

Mild 2–25

Moderate 25–50

Severe 50–83

Very Severe 83–103

A change of about 8 to 9 points on this scale is considered clinically meaningful, a large enough shift to matter in a child’s actual day-to-day comfort, not just on paper.

How PO-SCORAD Was Used in the Study

Researchers measured PO-SCORAD at baseline, 1, 2, and 6 months in 197 children enrolled in the Eczema Transformation Program. Here is what the average scores looked like over time:

Baseline

51.4

Severe

1 Month

40.1

Moderate

2 Months

33.6

Moderate

6 Months

24.2

Mild

That trajectory represents an average child moving from the severe range all the way into the mild range over six months, a 27.2-point average drop, or 52.9% improvement. Statistically, the improvement at every single time point was highly significant (p < 0.0001), and even after researchers adjusted for age, sex, allergy status, and medication use in a regression model, the six-month improvement remained large: 22.5 points.

See the full breakdown of these results, including the severe-symptom subgroup, in our companion post.

Why Researchers Chose This Tool

PO-SCORAD is widely used in eczema research specifically because it is validated, meaning it has been tested and shown to reliably reflect real symptom severity, and because it captures the parent’s actual lived experience of the condition, not just what is visible during a single appointment. For a study evaluating a whole-child, six-month program, a tool that could be completed monthly from home, and that reflected itch and sleep disruption alongside visible skin changes, was the right fit.

“The composite score allows patients to track eczema severity and changes over time,” is how the study’s own methodology describes it. For families, that tracking is often the first time the day-to-day chaos of eczema gets translated into a number they can actually watch change.

Frequently Asked Questions

What does PO-SCORAD stand for? Patient-Oriented Scoring of Atopic Dermatitis. It is a validated tool that measures eczema severity by combining affected skin area, symptom intensity, and subjective itch and sleep loss into a single score ranging from 0 to 103.

Is a lower or higher PO-SCORAD score better? Lower is better. A score of 0–2 is considered clear, 2–25 is mild, 25–50 is moderate, 50–83 is severe, and 83–103 is very severe.

How much of a PO-SCORAD change actually matters? Researchers consider an 8 to 9-point drop clinically meaningful, a large enough change to reflect a real difference in a child’s comfort and quality of life.

Who fills out PO-SCORAD? Parents or caregivers complete it, based on their observations of the child’s skin and their reports of itching and sleep loss over the prior three days.

How was PO-SCORAD used in the Frontiers in Allergy study? Researchers measured PO-SCORAD in 197 children at baseline and at 1, 2, and 6 months after starting the Eczema Transformation Program, finding an average 52.9% improvement at 6 months.

Curious What’s Driving Your Child’s Score?

Understanding the scoring tool is one thing. Understanding what is actually contributing to your own child’s eczema is another. Take our free two-minute Eczema Quiz to get a sense of the most likely factors behind your child’s symptoms, or watch the free masterclass where Dr. Ana-Maria Temple explains the framework behind the study’s results.

Read the Full Published Study →

This information is for educational purposes only and is not medical advice. Always consult your child’s medical team before making changes to medications, supplements, diet, or treatment plans.

My Latest Posts

Child Eating Vegitables

Severe Pediatric Eczema: What Happens to the Toughest Cases in Our Program

If your child’s eczema is not the occasional dry patch, if it is raw, weeping, bleeding, and covering large areas…

Read More...
Serawise Kids Supplements

What Is PO-SCORAD, and Why Does It Matter for Your Child’s Eczema?

If you have spent any time reading about the recent pediatric eczema study published in Frontiers in Allergy, you have…

Read More...
itching head

The Five Pillars of Root-Cause Eczema Support

When the results of the Frontiers in Allergy pediatric eczema study began circulating, one question kept coming up: “So what…

Read More...